Marc Tessier-Lavigne, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 12,191 shares at $675.00 ($8.3M) on 2022-03-16, disclosed to the SEC on 2022-03-18.
Open-market sale of $8.3M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $675.00 | 4,361 | $2.9M | 35.6% |
| 2 | $680.00 | 7,830 | $5.3M | 64.4% |
| Total | $678.21 avg | 12,191 | $8.3M | 100% |
| Filing → |
| REGN | SELL | 2022-10-03 | $10.2M | — | Filing → |
| DNLI | SELL | 2022-09-30 | $1.2M | — | Filing → |
| DNLI | SELL | 2022-08-25 | $632K | — | Filing → |